Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
Annotation


Li H, Wang B, Wang Z, Guo Q, Tabuchi K, Hammer RE, Südhof TC, Zheng H. Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP. Proc Natl Acad Sci U S A. 2010 Oct 5;107(40):17362-7. PubMed Abstract

  
Comments on Paper and Primary News
  Comment by:  Makoto Kuro-o
Submitted 26 September 2010  |  Permalink Posted 26 September 2010

The link between APP and Klotho is novel and very interesting. APP and Klotho share several common features: 1) They are single-pass transmembrane proteins with short intracellular domains; 2) they are substrates of α-, β-, and γ-secretases; 3) their extracellular domains are secreted and function as humoral factors.

Secreted Klotho has an activity that alleviates oxidative stress (Yamamoto et al., 2005) were reported to suffer cognitive impairment due to increased apoptosis of hippocampal neurons, which was rescued by administration of antioxidant (vitamin E) (Nagai et al., 2003).

Activation of BACE generates both Aβ and APPsβ. It will also facilitate secretion of Klotho. Thus, the ability of AAPsβ to increase Klotho expression may counteract harmful effects of Aβ by increasing secreted Klotho under the condition where BACE is activated. A major issue highlighted by this paper is a potential role of APP in the regulation of Klotho expression, the decline of which is known to...  Read more


  Comment by:  Virgil Muresan, Zoia Muresan
Submitted 27 September 2010  |  Permalink Posted 27 September 2010
  I recommend this paper

This interesting paper from Hui Zheng’s lab reminds us that there is still much to learn about the normal function of the amyloid-β precursor protein (APP). Of course, it also reminds us that there is so little that we know for sure about what APP normally does. It should also remind us that the pathology in Alzheimer disease could come, at least in part, from the loss of function of APP. Finally, this paper reminds us that the APP fragments, generated by secretase cleavage in multiple cellular compartments, have functions of their own. This paper clearly shows that the fragments (in this case, sAPPβ) and full-length APP have non-overlapping functions. Moreover, the paper shows that APP and the fragments can have different functions during development and in the adult organism.

This paper does not address the problem of where the sAPPβ is normally generated, nor does it address how it is transported to the cell periphery, where it is eventually secreted. As we recently showed, all APP polypeptides, typically derived through secretase cleavage, are incorporated into transport...  Read more

  Submit a Comment on this Paper
Cast your vote and/or make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend this paper

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 
 

REAGENTS/MATERIAL:
Antibodies and Reagents: mouse monoclonal anti-APP, amino terminal, aa.66-81 (22C11) (Millipore, Billerica, MA); mouse monoclonal anti-APP, carboxyl terminal, containing YENPTY (Y188) (Epitomics, Burlingame, California); The polyclonal anti-APPc was described previously. Rabbit anti-FLAG (Sigma Aldrich); mouse monoclonal anti-V5 (Abcam) and anti-synaptophysin (DAKO Cytomation). The α-bungarotoxin was from Molecular Probes.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad